$BDX

AI Analysis

Generated on May 11, 2026

AI Score
68/ 100
Hold$BDX

Becton Dickinson and Co.

$BDXNYSEHealthcareLarge-Cap

Becton Dickinson develops and sells medical technology products for medication management, diagnostics, and biosciences.

Market Cap
$68.0B
Revenue (TTM)
$20.2B
+4.0%
Net Income (TTM)
$1.8B
+6.0%
EPS (TTM)
$2.50
P/E Ratio
58.0
Dividend Yield
1.3%
52-Week Range
$215-$260
Beta
0.62
Dimension Scores
Fundamental
70
Technical
62
Sentiment
66
Risk / Reward
72
Momentum
58
FundTechSentRiskMome
Financial Health
Profitability
75moderate
Growth
61moderate
Liquidity
80strong
Solvency
72strong
Efficiency
68strong

Valuation, technical analysis, investment thesis, risk assessment and more for $BDX

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.